For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Research and development | 5,039 | 8,570* | 7,993 | 9,050 |
| Sales and marketing | 343 | 1,123* | 350 | 349 |
| General and administrative | 2,120 | 4,276* | 3,160 | 4,120 |
| Gain on lease modification, net | - | 235* | - | - |
| Total operating expenses | 7,502 | 13,733 | 11,503 | 13,519 |
| Loss from operations | -7,502 | -13,733* | -11,503 | -13,519 |
| Loss on disposal of leasehold improvements | - | -479* | - | - |
| Interest and other income | - | - | - | 264 |
| Change in fair value of warrant liabilities | - | 74* | -287 | - |
| Gain on sale of equipment | 133 | - | - | - |
| Change in fair value of warrant liabilities | - | - | - | -40 |
| Interest and other income, net | 40 | 514* | 158 | - |
| Loss before income taxes | - | - | -11,058 | -13,215 |
| Provision for income taxes | - | - | - | 0 |
| Total other income, net | 173 | -39* | - | - |
| Net loss | -7,329 | -13,772* | -11,058 | -13,215 |
| Net unrealized (loss) income on investments | - | -31 | 8 | - |
| Net unrealized loss on investments | -6 | - | - | -18 |
| Other comprehensive loss | -6 | -31* | 8 | -18 |
| Comprehensive net loss | -7,335 | -13,803 | -11,050 | -13,233 |
| Basic EPS | -1.03 | -2.124 | -1.86 | - |
| Diluted EPS | -1.03 | -2.124 | -1.86 | - |
| Basic Average Shares | 7,120,298 | 6,499,269 | 5,954,405 | 5,938,282 |
| Diluted Average Shares | 7,120,298 | 6,499,269 | 5,954,405 | 5,938,282 |
Vicarious Surgical Inc. (RBOT)
Vicarious Surgical Inc. (RBOT)